Russian Pharma Spending In 1996

18 May 1997

Russian drug imports totaled $1.1 billion in 1996, according to theMinistry of Health. Of the 1,550 billion rubles ($269.2 million) in 1996's federal budget allocation for drugs, only 727.7 billion rubles (46.6%) was actually spent on medicines.

It is reported that Russia's republics and provinces spent 4,990 billion rubles on drugs procurement in 1996, and that at April 15 this year, the federal budget drugs procurement debt had risen 26.7 billion rubles since the start of 1997 to 34.8 billion rubles. Federal budget spending on public-sector health care institutions in 1996 accounted for 57.7% of the level provided for in the budget. Drugs procurement was financed at only 50.6% of the target fixture, says the Ministry, making it impossible for medical institutions to provide the minimum required level of care.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight